Shares of Mylan (NYSE:MYL) plunged in Wednesday trading after the company reported disappointing fourth-quarter results. Mylan stock fell as much as 15% as a result and made new 52-week lows. This ...

This Oct. 10, 2013 file photo shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. (AP Photo/Mark Zaleski, File) NEW YORK • Dutch drugmaker Mylan says it will launch a ...

LONDON (MarketWatch) -- Pittsburgh drug maker Mylan said it priced its 1.86 million convertible preferred stock offering at $1,000 per share and its 53.5 million common stock offering at $14 a share.

The generic drug maker's stock climbs by more than 16 percent. Wall Street investors reacted favorably to Teva Pharmaceutical Industries’ decision to abandon its hostile takeover attempt for Mylan NV ...